Poseida Therapeutics Inc (PSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PSTX | AZN | AMGN | GILD | BMY |
| Company | Poseida Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 9.58 | 186.59 | 337.97 | 133.55 | 56.39 |
| High | 9.67 | 186.59 | 337.97 | 135.07 | 56.39 |
| Low | 9.49 | 186.59 | 337.97 | 131.88 | 56.39 |
| Latest | 9.50 | 185.12 | 333.56 | 133.29 | 56.40 |
| Change | -0.06 | -2.60 | -2.89 | +0.24 | +0.01 |
| % Change | -0.63% | -1.39% | -0.86% | +0.18% | +0.02% |
| Volume | 21,420,600 | 12,162 | 5,069 | 6,666,700 | 1,974 |
| 20-Day Average Volume | 2,215,435 | 2,014,388 | 2,591,788 | 6,210,530 | 9,802,733 |
| Previous Close | 9.56 | 187.72 | 336.45 | 134.94 | 56.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 9.48 | 188.27 | 338.44 | 133.00 | 57.79 |
| 20-Day Raw Stochastic | 46.87% | 26.05% | 47.97% | 42.85% | 18.33% |
| 20-Day Relative Strength | 78.00 | 45.39 | 46.47 | 45.77 | 44.08 |
| Weighted Alpha | -2.36 | +29.07 | +19.67 | +24.32 | +20.21 |
| Today's Opinion | 100% Buy | 8% Buy | 24% Sell | 24% Buy | 8% Buy |
| Previous Opinion | 100% Buy | 8% Buy | 24% Sell | 24% Buy | 16% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 24% Buy | 56% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 12/30/24 | +2.23% since 05/07/26 | +2.70% since 05/07/26 | -2.38% since 05/06/26 | +0.25% since 05/07/26 |
| Low | 9.39 on 01/03/25 | 181.58 on 05/08/26 | 327.62 on 05/11/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 9.67 on 01/07/25 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.02 on 05/12/26 |
| 1-Month | |||||
| %Chg | +1.50% since 12/06/24 | -8.70% since 04/14/26 | -3.70% since 04/14/26 | -4.30% since 04/13/26 | -2.91% since 04/14/26 |
| Low | 9.35 on 12/09/24 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 9.67 on 01/07/25 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +257.14% since 10/07/24 | -9.22% since 02/13/26 | -8.46% since 02/13/26 | -14.15% since 02/13/26 | -7.16% since 02/13/26 |
| Low | 2.32 on 10/31/24 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 9.67 on 01/07/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +218.79% since 07/05/24 | +4.71% since 11/14/25 | +0.37% since 11/14/25 | +6.27% since 11/13/25 | +20.88% since 11/14/25 |
| Low | 2.32 on 10/31/24 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 9.67 on 01/07/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 928,853 | 291,136,448 | 181,577,024 | 165,190,896 | 115,152,384 |
| Shares Outstanding, K | 97,774 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 64,700,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -123,430,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 71,750,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 20,240,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.63 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.21 on 11/07/24 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 03/06/25 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.93 | 15.22 | 16.12 | 9.52 |